Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders-The COVID-19 Arapahoe SErosurveillance Study (CASES) Project

J Occup Environ Med. 2021 Mar 1;63(3):191-198. doi: 10.1097/JOM.0000000000002099.

Abstract

Objectives: Define the seroprevalence and risk factors for SARS-CoV-2 antibodies in Arapahoe County, Colorado first responders (eg, law enforcement, human services, fire departments).

Methods: Two hundred sixty four first responders were enrolled June to July 2020. SARS-CoV-2 seropositivity was defined as detection of immunoglobulin G (IgG) antibodies to both spike receptor binding domain and nucleocapsid in venous blood by validated enzyme-linked immunosorbent assay. We compared risk factors for being seropositive versus seronegative.

Results: 4% (11/264) were SARS-CoV-2 seropositive. Seropositive participants were significantly more likely to have lung disease (% seropositive, % seronegative; P-value) (36%, 8%; P = 0.01), prior SARS-CoV-2/COVID-19 testing (36%, 8%; P ≤ 0.01), a prior positive result (18%, less than 1%), and to believe they previously had COVID-19 (64%, 15%; P < 0.01). Only 15% of those believing they had COVID-19 had anti-SARS-CoV-2 antibodies.

Conclusions: Human services employees and individuals with lung disease are at SARS-CoV-2 exposure risk. Few individuals believed they had COVID-19 had prior exposure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / pathology
  • COVID-19 / transmission
  • COVID-19 Serological Testing
  • Colorado / epidemiology
  • Emergency Responders / statistics & numerical data*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Risk Factors
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / isolation & purification
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral
  • Immunoglobulin G